CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Deposit Assets
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Deposit Assets of -$17.51 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositOtherAssets · last filed 2017-05-11
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for the quarter ending 2017-03-31 was -$17.51K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for the quarter ending 2016-12-31 was $531.38K, a 79.48% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for the quarter ending 2016-09-30 was $144.15K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for the quarter ending 2016-06-30 was -$202.71K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for fiscal 2016 was $380.78K, a 54.86% decline from fiscal 2015.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for fiscal 2015 was $843.64K, a 34.28% decline from fiscal 2014.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for fiscal 2014 was $1.28M.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in deposit assets for fiscal 2013 was -$2.63M, a 358.74% decline from fiscal 2012.
| Period end | Increase (Decrease) in Deposit Assets 3 month | Increase (Decrease) in Deposit Assets 6 month | Increase (Decrease) in Deposit Assets 9 month | Increase (Decrease) in Deposit Assets 12 month | Increase (Decrease) in Deposit Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2017-03-31 | -$17.51K 10-Q · filed 2017-05-11 | $513.88K derived: sum of 2 quarters · filed 2017-05-11 | $658.02K derived: sum of 3 quarters · filed 2017-05-11 | $455.31K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-12-31 | $531.38K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $675.53K derived: sum of 2 quarters · filed 2017-03-31 | $472.82K derived: sum of 3 quarters · filed 2017-03-31 | $380.78K 10-K · filed 2017-03-31 | |
| 2016-09-30 | $144.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$58.57K derived: sum of 2 quarters · filed 2016-11-14 | -$150.61K 10-Q · filed 2016-11-14 | $2.44M derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-06-30 | -$202.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$294.75K 10-Q · filed 2016-08-11 | $2.30M derived: sum of 3 quarters · filed 2017-05-11 | $1.04M derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-03-31 | -$92.04K 10-Q · filed 2017-05-11 | $2.50M derived: sum of 2 quarters · filed 2017-05-11 | $1.25M derived: sum of 3 quarters · filed 2017-05-11 | $906.17K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2015-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $1.34M derived: sum of 2 quarters · filed 2017-03-31 | $998.21K derived: sum of 3 quarters · filed 2017-03-31 | $843.64K 10-K · filed 2017-03-31 | $5.14M 10-K · filed 2016-03-30 |
| 2015-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.59M derived: sum of 2 quarters · filed 2016-11-14 | -$1.75M 10-Q · filed 2016-11-14 | $1.01M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | -$340.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$494.83K 10-Q · filed 2016-08-11 | $2.26M derived: sum of 3 quarters · filed 2016-08-11 | $358.80K derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | -$154.57K 10-Q · filed 2016-05-16 | $2.60M derived: sum of 2 quarters · filed 2016-05-16 | $699.06K derived: sum of 3 quarters · filed 2016-05-16 | $1.16M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $853.63K derived: sum of 2 quarters · filed 2016-03-30 | $1.31M derived: sum of 3 quarters · filed 2016-03-30 | $1.28M 10-K · filed 2016-03-30 | -$296.98K 10-K · filed 2015-03-30 |
| 2014-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | -$1.44M derived: sum of 2 quarters · filed 2015-12-28 | -$1.47M 10-Q · filed 2015-12-28 | ||
| 2014-06-30 | $459.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $430.00K 10-Q · filed 2015-12-28 | |||
| 2014-03-31 | -$29.25K 10-Q · filed 2015-12-28 | ||||
| 2013-12-31 | -$2.63M 10-K · filed 2015-12-28 | ||||
| 2012-12-31 | $1.01M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |